Orrick and Pavia Ansaldo for 1000Farmacie’s Series A
Milan, 31 July 2023 – Orrick has assisted 1000Farmacie S.p.A., an Italian online pharmacy marketplace, in completing an extension tranche of the Series A investment round closed in 2022, which resulted in the startup raising an additional $15 million, for a total of $25 million of the entire Series A round.
The investors who participated in the round include, among others, the lead investor of the extension tranche GG 1978, as well as P101, with the P102 and ITA 500 funds – Azimut, HBM Healthcare Investments, LIFTT, IAG, Club degli Investitori, Healthware Ventures and Feel Venture, which had also participated in the first tranche of Series A. In particular, GG 1978 was assisted by the firm Pavia Ansaldo in negotiating the investment.
An important focus of 1000Farmacie’s expansion strategy will be the prescription (RX) market, in particular the provision of an innovative home delivery service dedicated to chronic patients.
Orrick assisted 1000Farmacie with a team led by Attilio Mazzilli, head of the Technology Companies Group, and comprising senior associate Pietro Fazzini, associate Elena Cozzupoli and Camilla Larcher.
For the lead investor GG 1978 acted the Head of Legal of GISEV Family Office Luca Barlassina and the law firm Pavia Ansaldo with a team composed of partner Carlo Trucco and trainee associate Beatrice Trombi.